Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial - Fakih, MG; Kopetz, S; Kuboki, Y (Lancet Oncol, 2022)